Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide

Pediatric Dermatology

Volumn 23, Issue 4, 2006, Pages 386-389

  Kimata, Hajime ^a,b  

^a Satou Hospital   (Japan)

^b Satou Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; KONJAC CERAMIDE; LACTOSE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SCORAD INDEX; SKIN ALLERGY; SKIN MANIFESTATION; SKIN TEST; TH1 CELL;

ADMINISTRATION, ORAL; AMORPHOPHALLUS; CERAMIDES; CHILD; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DOUBLE-BLIND METHOD; DUST; HUMANS; PHYTOTHERAPY; REFERENCE VALUES; SKIN;

EID: 33746877816     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2006.00268.x     Document Type: Article

References (15)

1. Hanfin JM, Rajika G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92(Suppl.):44-47.
2. Macheleidt O, Kaiser HW, Sandohoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119:166-173.
3. Beradsca E, Barbareschi M, Veraldi S et al. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis 2001;45:280-285.
4. Chamlin SL, Kao J, Friden IJ et al. Ceramide-dominant barrier repair alleviates childhood atopic dermatitis: changes in barrier function provides a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208.
5. Yajima J. Allergic contact dermatitis due to hydrophilized ceramide. Contact Dermatitis 2002;47:245.
6. Mukai K. The function of an edible ceramide extracted from a tuber of Konjac. Bio Ind 2002;19:16-26 (In Japanese).
7. Kimata H. Reduction of allergen-specific IgE production by laughter. Eur J Clin Invest 2004;34:76-77.
8. Kunz B, Oranje AP, Labreze L et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19.
9. Kimata H. Suckling reduces allergic skin responses and plasma levels of neuropeptide and neurotrophin in lactating women with atopic eczema/dermatitis syndrome. Int Arch Allergy Immunol 2003;132:380-383.
10. Kimata H. Cholesterol selectively enhances in vitro latex-specific IgE production in atopic dermatitis patients with latex allergy. Life Sci 2005;76:1527-1532.
11. Kimata H. Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in a patient with atopic eczema/dermatitis syndrome. Brain Behav Immun 2003;17:134-138.
12. Ueda Y, Sone T, Inagaki N et al. Effects of prednisolone on the cutaneous reaction and skin barrier function in mice treated with a hapten. Biol Pharm Bull 2003;26:618-621.
13. Santa K, Watanabe K, Nakada T et al. Enhanced expression of B7.2 (CD88) by percutaneous sensitization with house dust mite antigen. Immunol Lett 2003;85:5-12.
14. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a TH2-domonant cytokine responses. Eur J Immunol 1998;28:769-779.
15. Miyanishi K, Shiono N, Shirai H et al. Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy (in press).